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ABSTRACT 
Background 
Bipolar disorder (BD) is difficult to diagnose in the early stages of the illness, with the 
most frequent misdiagnosis being major depressive disorder (MDD). We aimed to use 
a regional homogeneity (ReHo) approach with  resting-state functional magnetic 
resonance imaging (rs-fMRI) to investigate the features of spontaneous brain activity 
in MDD patients screening positive on the 32-item Hypomania Checklist (HCL-32).  
 
                                                        
1 Haichen Yang, Linling Li, Hongjun Peng contributed equally，they are co-first authors. 
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Methods 
Nineteen MDD patients screening positive (HCL-32(+); 9 males; 24.9 ± 5.7 years) and 
18 patients screening negative (HCL-32(-); 9 males; 27.1 ± 6.7 years), together with 
24 healthy controls (HC; 11 males; 26.4 ± 3.9 years) were studied. ReHo maps were 
compared and an receiver operating characteristic (ROC) analysis was conducted to 
confirm the utility of the identified ReHo differences in classifying the patients. 
 
Results 
The MDD versus HC showed different ReHo in many brain areas, especially in the 
frontal and parietal cortex. The HCL-32(+) versus HCL-32(-) showed significant 
increase of ReHo in the right medial superior frontal cortex, left inferior parietal cortex 
and middle/inferior temporal cortex, and decrease of ReHo in the left postcentral 
cortex and cerebellum. ROC analysis showed good sensitivity and specificity for 
distinguishing these two subgroups of MDD. 
 
Limitations 
Recruited patients were all on antidepressants and standard mania rating scales were 
not used to assess their hypomanic symptoms.  
 
Conclusions 
The rs-fMRI measurement of ReHo in distributed brain regions may be putative 
biomarkers which could differentiate subthreshold BD from MDD. 
 
Keywords: Major depressive disorder, HCL-32, Resting-state fMRI, Regional 
homogeneity 
 
1. Introduction 
Bipolar disorder (BD) is a common, chronic and complex disease, which can 
cause psychosocial impairment and has both high mortality and morbidity rates 
(Angst, 1999; Kemp et al., 2008; Merikangas et al., 2007; Murray and Lopez, 1997). 
However, it is often difficult to make a correct early diagnosis of BD. Over one third of 
BD patients may wait 10 years or more before receiving an accurate diagnosis 
(Hirschfeld et al., 2003). Up to sixty-nine percent of BD patients may be initially 
misdiagnosed, with the most frequent misdiagnosis being major depressive disorder 
(MDD) (Hirschfeld et al., 2003).  This is undoubtedly partly because a depressive 
episode is usually the first mood syndrome at the onset of BD and depressive 
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episodes are more frequent than manic/hypomanic episodes (Solomon et al., 2006) 
(Hirschfeld et al., 2003; Solomon et al., 2006).  
MDD patients can be divided into positive (+) and negative (-) subgroups 
according to self-rating screening instruments for BD. The 32-item Hypomania 
Checklist (HCL-32) has been widely used as a screening instrument for BD in clinical 
psychiatry in the past decade (Yang et al., 2012; Yang et al., 2011). In the case of 
HCL-32, MDD patients (identified by the 4th edition of the Diagnostic and Statistical 
Manual of Mental Disorders; DSM-IV) can be stratified by HCL-32 scores according to 
the cutoff score between BD and MDD (Angst et al., 2005; Fornaro et al., 2013; Hu et 
al., 2012). This stratification thus results in one group of patients scoring positive for 
BD (HCL-32(+)) and another group scoring negative for BD (HCL-32(-)). Some 
researchers consider HCL-32(+) patients as subthreshold BD patients and HCL-32(-) 
patients as patients with “true” unipolar MDD (Fornaro et al., 2013; Hu et al., 2012). 
Follow-up studies have shown that the rates of diagnostic change to full-blown BD are 
significantly higher in HCL-32(+) patients than the rates in HCL-32(-) patients 
(Biederman et al., 2014; Holma et al., 2008).  
Task-related functional magnetic resonance imaging (fMRI) studies suggest that 
MDD is associated with abnormalities of a complex series of brain regions (Fitzgerald 
et al., 2008). The resting-state fMRI (rs-fMRI) is a task-free technique which measures 
spontaneous brain activities as low-frequency fluctuations in blood oxygen 
level-dependent (BOLD) signals in the resting brain (Biswal et al., 1995). Instead of 
focusing on the neural responses under task conditions, rs-fMRI has been utilized to 
investigate the integration level of neural systems when a non explicit task is engaged 
(Fox and Raichle, 2007). This rs-fMRI technique has been demonstrated to be a 
powerful tool which reliably characterizes resting-state brain activities. However, it is 
important to take into account the abnormalities of neural activities at the baseline 
state when explaining findings obtained during the task-performing state. Additionally, 
rs-fMRI is simple and easier operationally compared to task-related fMRI.  
The rs-fMRI data analyses includes functional connectivity and voxel-wise metrics 
of local brain activity. As shown in functional connectivity studies of MDD, affective 
disorders have been linked to alterations of the default mode network (DMN), the 
affective network (AN), the salience network (SN), and the cognitive control network 
(CCN) (Dutta et al., 2014). Thus, it is meaningful to investigate  if localized 
dysfunction of specialized brain regions contributes to network-level abnormalities. 
Currently, local brain activity information can be assessed by rs-fMRI metrics including 
regional homogeneity (ReHo), amplitude of low frequency fluctuation (ALFF), 
fractional amplitude of low-frequency fluctuation (fALFF), voxel-mirrored homotopic 
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connectivity (VMHC) and so on (Zuo and Xing, 2014). ALFF was proposed to 
measure the intensities of the moment-to-moment low-frequency fluctuations in the 
fMRI time series (Yu-Feng et al., 2007). ALFF, as well as its normalized version fALFF, 
is a useful approach with which to map the voxel-wise spatial distribution or regional 
variation of low-frequency fluctuations across the entire brain. Abnormal baseline 
ALFF values have been identified in the depressive episode of BD within the 
prefrontal-limbic network (Liu et al., 2012a; Liu et al., 2012c). We applied an ReHo 
analysis to processed data in this study. According to one study about the test-retest 
reliability of voxel-wise rs-fMRI metrics, local functional homogeneity was one of the 
mostly reliable rs-fMRI metrics (Zuo and Xing, 2014).  
The ReHo analysis was originally proposed to measure the degree of signal 
synchronization of fMRI time-courses (Zang et al., 2004). The hemodynamic 
characteristics of every voxel within a functional cluster are assumed to be similar and 
there is a dynamic synchronization of voxels within a cluster. The ReHo method can 
beused to assess the consistency of a conglomeration of BOLD time series. 
Therefore, ReHo reflects the temporal homogeneity of the regional BOLD signal, 
rather than its density and signal intensity (Zang et al., 2004). Abnormal ReHo is 
considered to be related to changes in the temporal aspects of spontaneous neural 
activity in the regional brain (Wu et al., 2010).  ReHo abnormalities (either increase 
or decrease in ReHo value) are related to unbalanced local brain activity. In recent 
years, ReHo has been successfully used to investigate the brain function in healthy 
subjects (Kunisato et al., 2011; Luo et al., 2014) and clinical populations with 
psychiatric disorders (Chen et al., 2012; Guo et al., 2011; Liang et al., 2013; Liu et al., 
2012e; Zang et al., 2004). For MDD, extensively distributed abnormal brain activities 
have been observed during resting-state and some clinical symptoms have been 
related to specific abnormal patterns of brain activities (Yao et al., 2009).  Previously, 
regional ReHo differences have been tested  as a differential diagnosis tool of BD 
and MDD (Liu et al., 2013a). However, it is not clear whether there are differences in 
brain activity between the two subgroups of MDD patients which are the subject of this 
study, i.e., HCL-32(+) patients and HCL-32(-) patients. 
In this study, we focused on the whole brain ReHo comparison between these two 
MDD subgroups. We hypothesized that the HCL-32(+) MDD patients would be 
different from those HCL-32(-) MDD patients in resting-state brain function and such 
differences would be captured by the ReHo analysis. If present, any of these 
differences may be putative biomarker distinguishing HCL-32(+) patients from those 
patients with “true” MDD. 
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2. Methods 
2.1 Subjects 
All patients were recruited from outpatient departments and inpatient units at the 
department of Psychiatry, Second Xiangya Hospital of Central South University, from 
April 2012 to June 2013. The inclusion criteria for patients with MDD were: (1) age ≥ 
18 and ≤ 60 years and ability to give voluntary informed consent; and that they (2) met 
the DSM-IV SCID (Structured Clinical Interview for DSM-IV) criteria for MDD and a 
current major depressive episode (First and Gibbon, 1997; First et al., 2002b); (3) had 
a total score of 17-item Hamilton Depression Rating Scale (HDRS) ≥ 17 (Hamilton, 
1969); (3) satisfied criteria for undergoing magnetic resonance imaging (MRI) 
scanning based on a screening questionnaire; and (4) had not received 
electroconvulsive therapy (ECT) in the past four weeks. The diagnoses of MDD were 
made according to the SCID criteria by two experienced psychiatrists (First and 
Gibbon, 1997), both of whom had completed a 2-week training program before the 
diagnostic assessment. The inter-rater reliability of the SCID was tested and yielded 
satisfactory agreement (Kappa = 0.91). In total, 43 currently depressed MDD patients 
were enrolled in this study. The HCL-32, as well as HDRS and Hamilton Anxiety 
Rating Scale (HAMA) were administered after the patients completed the consent 
procedure. The HCL-32 is a self-report questionnaire which screens for hypomania 
(Angst et al., 2005). The multi-lingual hypomania checklist (HCL-32) has been 
developed and has been widely tested internationally. The Chinese version has 
acceptable psychometric reliability and validity in patients with BD (Yang et al., 2008; 
Yang et al., 2012; Yang et al., 2010; Yang et al., 2011). We used the cutoff of 12, 
which was the optimal discriminator between MDD and type II BD instead of 14, which 
was the optimal cutoff between MDD and all BD (Yang et al., 2012; Yang et al., 2011). 
In China, at the cutoff of 12 between BD and MDD, the sensitivity is 0.86, and the 
specificity 0.69 (Yang et al., 2012; Yang et al., 2011). The MDD patients with a 
HCL-32 score higher than or equal to 12 were defined in this study as HCL-32(+) 
patients, and those with a HCL-32 score lower than 12 as HCL-32(-) patients. 
Healthy controls (HC) were recruited by poster or advertisement in local 
newspapers. Subjects were excluded if they had: (1) a current or past psychiatric 
diagnosis; (2) organic brain disease; (3) a history of head trauma resulting in loss of 
consciousness longer than 10 minutes; (4) a history of substance or alcohol 
dependence within the 12 months before assessment; (5) a first degree family history 
of any major psychiatric disorders, dementia, or mental retardation. The non-patient 
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version of the SCID was used to ensure that the healthy subjects had no history of 
psychiatric or neurologic illness (First et al., 2002a). In total, 26 healthy subjects were 
enrolled in this study. 
All the MDD patients and healthy subjects enrolled in this study were right-handed, 
as measured by the Edinburgh Inventory (Oldfield, 1971). This study was approved by 
the Institutional Review Board of the Second Xiangya Hospital. Subjects provided 
both oral and written informed consent prior to any study-related procedures. The MRI 
scanning was performed for each patient within one week of the clinical assessment. 
2.2 MRI image acquisition 
MRI scanning was performed on a 3.0 T Philips 3T magnetic resonance system 
(Philips, Best, Netherlands) in the Second Xiangya Hospital of Central South 
University. Subjects were in the supine position with their heads snugly fixed by a belt 
and foam pads to minimize head motion. The scanning session included: (1) 
localization; (2) a 3-dimensional high-resolution T1-weighted anatomical image (TR = 
1900 ms, TE = 2.53 ms, TI = 900 ms, FA = 9°, FOV = 240×240 mm2, matrix = 
256×256, slice number = 176, voxel size = 0.9×0.9×1 mm3) was acquired; (3) rs-fMRI 
images were acquired with 36 axial slices, TR = 3000 ms, TE = 30 ms, FA = 90°, 
thickness/gap = 4/0 mm, FOV = 240 mm × 240 mm, and matrix = 64 × 64. The fMRI 
scanning lasted for 9 min, and subjects were asked to keep their eyes closed and not 
to think about anything in particular.  
2.3 MRI data analysis 
Imaging preprocessing and ReHo analysis was conducted using a MATLAB 
toolbox called Data Processing Assistant for Resting-State fMRI (DPARSF, the State 
Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, 
Beijing, China) (Chao-Gan and Yu-Feng, 2010). Between-group comparisons were 
carried out with the SPM8 toolbox (http://www.fil.ion.ucl.ac.uk/spm). 
The first 10 volumes of the resting-state images were discarded because of 
magnetic saturation effects. The remaining 170 images were corrected for the 
acquisition delay between slices and for the head motion through slice timing and 
motion correction. Subjects who had more than 2 mm maximum displacement and 2° 
of angular motion during the whole resting fMRI scanning were excluded from the 
subsequent analysis. 6 MDD patients and 2 healthy subjects were excluded because 
of excessive head motion. As described in previous studies, head motion can 
significantly influence rs-fMRI metrics and results derived (Van Dijk et al., 2012). 
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Therefore, volume-level the mean framewise displacements (FD) were computed 
(Power et al., 2012). As results, MDD and HC did not differ in mean FD (independent 
two-sample t-test: t(59) = -0.718, p = 0.476; MDD: 0.16 ± 0.03 mm; HCs: 0.19 ± 0.03 
mm). And HCL-32(+) and HCL-32(-) did not differ in mean FD (independent 
two-sample t-test: t(35) = -1.075, P = 0.290; HCL-32(+): 0.14 ± 0.02 mm; HCL-32(-): 
0.19 ± 0.05 mm). Each individual structural image was first coregistered with the 
mean functional image and then segmented into gray matter (GM), white matter (WM) 
and cerebrospinal fluid (CSF) using a unified segmentation algorithm. A local brain 
template was generated using diffeomorphic anatomical registration through 
exponential liealgebra (DARTEL). In order to reduce the potential effects of 
physiological process and motion, 26 nuisance covariates (including signals from WM, 
CSF and Friston 24 motion parameters were regressed out (Power et al., 2012; Van 
Dijk et al., 2012).The functional images were then temporally band-pass filtered 
(0.01-0.08 Hz) to reduce the effect of low-frequency drifts and high-frequency noise 
(Biswal et al., 1995; Lowe et al., 1998). Normalization and smoothing was performed 
later after ReHo maps calculation in original space.  
For each individual, a ReHo map was generated which included the Kendall’s 
coefficient of concordance (KCC) of each voxel within its nearest neighbors (26 voxels) 
in a voxel-wise analysis (Chao-Gan and Yu-Feng, 2010; Zang et al., 2004). To reduce 
the influence of individual variations in the KCC value, standardization of ReHo maps 
were performed by dividing the KCC of a given voxel by the averaged KCC of the 
whole brain. Then the standardized ReHo maps were spatially normalized to the 
Montreal Neurological Institute (MNI) template and resampled at a resolution of 
3×3×3 mm3 using the normalization parameters estimated during unified 
segmentation, and finally smoothed with a Gaussian kernel of 4 mm full-width at 
half-maximum to reduce noise. The resulting ReHo maps were entered into second 
level analyses for between-group comparisons. 
2.4 Statistical analysis 
Subjective characteristics were analyzed by SPSS (IBM SPSS Statistics for 
Windows; Armonk, NY: IBM Corp). Chi-square tests were performed to assess the 
differences in gender and two sample t-tests were performed to assess the 
differences in FD, age, age of onset, education, HAMA, HDRS and HCL-32 scores. 
Mann-Whitney U test was applied to compare disease duration between HCL-32(+) 
and HCL-32(-). 
ReHo maps of all subjects were entered into a two-sample test contrasting the 
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MDD group with the HC group. Then another two-sample t-test was done contrasting 
the HCL-32(+) versus the HCL-32(-). Voxels with a P value < 0.005 and cluster size > 
13 were considered to show significant difference, which was equal to a corrected 
threshold of P < 0.05, determined by the Monte Carlo stimulation (the AlphaSim 
program in DPARSF toolbox). The Parameters were: single voxel P = 0.005, 1000 
simulations, FWHM = 4 mm, cluster connection radius r = 5 mm. Results of group 
analyses were displayed by superimposing the T statistic maps on a standard 
high-resolution T1-weighted brain template using MRIcroN software 
(http://www.mricro.com).  
Brain regions displaying significant differences between the HCL-32(+) and the 
HCL-32(-) groups were identified as regions of interest (ROIs) and the mean ReHo 
values were extracted for each subject. We correlated the mean ReHo values of these 
five ROIs with the demographic measures, including disease duration, HAMA scores, 
and HDRS score. Correlation analyses between mean ReHo values and HCL-32 
scores were performed for HCL-32(+) group and HCL-32(-) group separately. 
We also performed an receiver operating characteristic (ROC) analysis to examine 
whether these ROIs could be used as biomarkers to discriminate the HCL-32(+) 
group from HCL-32(-) group as the ROC analysis has been commonly used to 
summarize the sensitivity and specificity of a biomarker for distinguishing subject 
groups (Liu et al., 2012d; Liu et al., 2013b).  
3. Results 
3.1 Demographic and clinical characteristics 
Twenty-four patients were defined as HCL-32(+) because their HCL-32 scores 
were equal to or higher than 12. The HCL-32 scores of 19 patients were lower than 12 
and they were defined as HCL-32(-). Five HCL-32(+) patients, one HCL-32(-) patient 
and two healthy subjects were excluded because of excessive head motion. 
Eventually, there were 19 patients in HCL-32(+) group, 18 patients in HCL-32(-) group 
and 24 subjects in HC group. All patients with MDD were taking antidepressants at 
the time of fMRI scanning. In HCL-32(+) group, 16 patients were being treated with 
selective serotonin reuptake inhibitors (SSRIs), and 3 with venlafaxine. In HCL-32(-) 
group, 16 patients were being treated with SSRIs, and 2 with venlafaxine. The 
demographic and clinical characteristics of all subjects included in the final data 
analysis are presented in Table 1. 
The MDD group and the HC group did not differ significantly in gender, age, 
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education level (gender: X(1) = 0.046, p = 0.830; age: t(59) = -0.312, p = 0.756; 
education: t(59) = -1.954, p = 0.055). The MDD group had statistically higher HAMA 
and HDRS score than HC group (HAMA: t(59) = 17.667, p = 0.000; HDRS: t(59) = 
25.063, p = 0.000). Besides, these two subgroups were matched for gender, age, 
education level, disease duration and age of onset (gender: X(1) = 0.026, p = 0.873; 
age: t(35) = -1.089, p = 0.284; education level: t(35) = 1.440, p = 0.159; disease 
duration: U = 163, p = 0.807; age of onset: t(35) = -1.504, p = 0.141). There was no 
significant difference of HAMA and HDRS score between these two subgroups 
(HAMA: t(35) =1.222, p = 0.230; HDRS: t(35) = 0.368, p = 0.715). HCL-32 score of 
HCL-32(+) group was significantly higher than HCL-32(-) group  (t(35) = 12.468, p = 
0.000). 
3.2 ReHo profiles 
Compared to HC group, the MDD group showed significant increased and 
decreased ReHo values in many brain regions, such as the bilateral frontal cortex, 
bilateral postcentral cortex, bilateral superior temporal cortex (STC), left inferior 
occipital cortex (IOC), bilateral middle cingulate cortex (MCC), angular gyrus, 
precuneus, parahippocampal gyrus, insular and cerebellum (Table 2).  
Significant ReHo differences derived from comparison between HCL-32(+) and 
HCL-32(-) are showed in Table 3 and Fig. 1. HCL-32(+) patients showed significantly 
increased ReHo values in the right medial superior frontal cortex (MSFC), left inferior 
parietal cortex (IPC) and left middle/inferior temporal cortex (MTC/ITC), and 
decreased ReHo in the left postcentral cortex and cerebellum. 
3.3 ROI-wise ReHo analysis 
Mean ReHo values of those five above-mentioned clusters (MSFC, IPC, MTC/ITC, 
postcentral cortex and cerebellum) were extracted. For all MDD patients, mean ReHo 
value of IPC showed positive correlation with disease duration (r = 0.381, p = 0.020). 
No other significant correlation was identified. By ROC curves analyses (as shown in 
Table 4 and Fig. 2), the areas under the curves (AUC) of these five ROIs were good 
(0.830 − 0.871).  
 
4. Discussion 
MDD is a serious condition with disrupted neural network underlying mood and 
cognition processing (Zhang et al., 2011). In this study, compared to healthy subjects, 
MDD patients exhibited abnormal resting-state brain activities in the MSFC, IPC, STC, 
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angular gyrus, precuneus, parahippocampal gyrus, insular and cerebellum. Most of 
these brain regions are considered to belong to the default mode network (DMN) 
which is one of the most commonly recognized resting-state networks in the brain. 
DMN is relevant to the origin and experience of mood and psychotic symptoms 
(Pomarol-Clotet et al., 2012; Whitfield-Gabrieli and Ford, 2012). Evidence has 
showed that DMN plays a key role in neural activities mediating MDD (Sheline et al., 
2010; Zhou et al., 2010).  
This study focused on the investigation of the differences between two MDD 
subgroups in brain activities during resting-state. We found that the HCL-32(+) group 
showed significant increase of ReHo in the right MSFC, left IPC, left MTC/ITC and 
significant decrease of ReHo in the left postcentral cortex and cerebellum compared 
to the HCL-32(-) group. ROC analysis was performed to summarize the sensitivity 
and specificity of these five ROIs for distinguishing these two subgroups of MDD. The 
AUC values of these five ROIs were 0.845, 0.830, 0.848, 0.871 and 0.871 respectively. 
The discrimination results of ROC analysis was commonly considered excellent for 
AUC values between 0.9 and 1, good for AUC values between 0.8 and 0.9, fair for 
AUC values between 0.7 and 0.8, poor for AUC values between 0.6 and 0.7 and failed 
for AUC values between 0.5 and 0.6 (El Khouli et al., 2009; Ludemann et al., 2006; 
Obuchowski, 2003). According to these criteria, these five ROIs showed good 
performance to distinguish HCL-32(+) patients from HCL-32(-) patients. 
The MSFC plays a role in the integration of emotional and cognitive processes by 
incorporating emotional biasing signals or markers into decision making processes 
(Bechara et al., 1994) and has extensive reciprocal connections to the limbic 
structures (Ongur and Price, 2000). The MSFC has been suggested to be related to 
the emotional regulation impairment in BD (Phillips et al., 2008). BD patients exhibited 
increased functional connectiv 
 
ity between MSFC and amygdale while viewing sad stimuli compared with HC 
(Versace et al., 2010). And the effective connectivity between MSFC and amygdale 
has been shown to differentiate BD from MDD (de Almeida et al., 2009). These results 
suggested that MSFC was one of the most important brain areas underlie the affective 
disturbance in BD (Vargas et al., 2013). In this study, HCL-32(+) patients versus 
HCL-32(-) patients exhibited increased ReHo in the right MSFC. So, it was 
demonstrated again that MSFC might be used to differentiate BD from MDD.  
The IPC lies at a key location in the brain, at the junction of the auditory, visual, 
and somatosensory cortex, with which it is highly connected. The bilateral IPC was 
consistently identified in the DMN and was considered to be implicated in emotion 
  11 
processing (Canli et al., 2004). For MDD, the IPC was proposed as one of the “core 
nodes” of the dysfunctional intrinsic organization (Zhou et al., 2010). However, the 
IPC has also been found to be involved in a wide range of different processes, 
ranging from action, memory, and language to mathematical problem solving and 
social cognition (Rolls, 1999). Comparing with HC, increased ReHo values in the IPC 
have been observed in both BD and UD, but no difference was identified when 
comparing with each other (Liang et al., 2013). Then the authors suggested that the 
ReHo abnormalities in IPC might be attributed to learning disabilities with parietal 
dysfunction because that depressed patients usually had low level of education 
compared with normal subjects (Liang et al., 2013; Shippee et al., 2011). We 
observed increased ReHo in the IPC for MDD patients comparing with HC, as well as 
for HCL-32(+) compared with HCL-32(-). The HCL-32(+) and HCL-32(-) patients 
showed no statistical difference on the level of education. Besides, mean ReHo value 
of IPC showed positive correlation with disease duration. So, the different ReHo 
values between these two subgroups might be attributed to distinguishing features of 
emotion processing dysfunction. Besides, the postcentral cortex in the parietal lobe 
showed lower ReHo values in HCL-32(+) patients compared with HCL-32(-) patients. 
The postcentral cortex is conceived as primary somatosensory cortex, and receives 
the bulk of the thalamocortical projection from the sensory input fields. BD patients (in 
depressive state) showed significant lower ReHo and ALFF in left postcentral cortex 
compared to HC (Liang et al., 2013; Liu et al., 2012a). However, more straightforward 
evidences are needed to interpret the implication of the abnormal brain activities in 
the postcentral cortex. 
Besides, the HCL-32(+) patients exhibited significantly higher ReHo values in the 
MTC/ITC than those of HCL-32(-) patients. Previous studies found no difference of 
local region activity in MTC/ITC for BD compared with HC or UD (Liang et al., 2013; 
Liu et al., 2012b; Liu et al., 2012c; Liu et al., 2012d). But functional connectivity 
between MTC and other emotion regulation related brain regions, such as prefrontal 
cortex, has been found increased in patients with MDD (Zhou et al., 2010) and this 
abnormal activity might be resulted from negative experiences or represent a dynamic 
prediction of expected future coactivations as a results of the overall negative 
expectations of depressed patients (Fox et al., 2006). The ITC is also involved in the 
processing of working memory (Axmacher et al., 2008), and complex emotional visual 
stimuli (Geday et al., 2007). It has also been reported that the ITC demonstrated 
structural (Wu et al., 2011) and functional abnormalities, which correlated with 
self-reported anxiety (Kroes et al., 2011). In this study, we identified higher ReHo 
values in HCL-32(+) patients and this issue still awaits in-depth explanation with 
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future confirmation. 
In consistent with this study, increased ReHo in the posterior lobe of cerebellum 
has been observed in MDD (Liu et al., 2010). There are evidences from neuroimaging 
studies that the cerebellum plays a role in the emotional and cognitive processing of 
negative stimuli (Schraa-Tam et al., 2012). The important role of the cerebellum in the 
cerebellar cognitive affective syndrome has been described in healthy subjects 
(Schmahmann, 2004; Schmahmann and Sherman, 1998). And the cerebellum has 
been previously identified as relevant to depression because of the increase in resting 
anterior cerebellar activity and the abnormal responses of cerebellar activation to both 
positive and negative affect (Fitzgerald et al., 2008). Cerebellar abnormalities with 
increased ReHo have been observed in BD compared with UD (Liu et al., 2012d), but 
no ReHo difference was found in another study (Liang et al., 2013). In this study, 
HCL-32(+) patients versus HCL-32(-) patients showed decreased ReHo in cerebellum. 
These inconsistencies may be attributed to several confounding factors of enrolled 
patients, such as depression severity, diverse medication. 
5. Limitations 
There are several limitations to be noted regarding this study. First, the number of 
depressive episodes and ratings of standard mania scales were not recorded and 
therefore we couldn’t make complete description about all the clinical features as well 
as their correlation with brain activity. Second, the antidepressants and relative larger 
age range might have impacts on the neuronal activity of the resting brain (Fang et al., 
2015). Third, the results would be more persuasive if the ROC analysis could be 
performed with another group of patients (Kriegeskorte et al., 2009). Forth, BD 
patients were not enrolled to perform direct comparison of BD and HCL-32(+). Last 
but not least, follow-up tests were not included and more straight evidence could be 
provided with longitudinal study design, considering that 8.9% subjects with previous 
unipolar MDD switched to BD type II and 2.8% to BD type I after a 5-year follow-up 
(Holma et al., 2008).  
6. Conclusions 
In summary, we found that the HCL-32(+) patients showed significant increase of 
ReHo in the right MSFC, left IPC, left MTC/ITC and significant decrease of ReHo in 
the left postcentral cortex and cerebellum compared to HCL-32(-) patients. According 
to the results of ROC analysis, the alterations of ReHo in these five brain regions 
showed good performance to differentiate HCL-32(+) patients from HCL-32(-) patients. 
The features of ReHo in these regions may be regarded as putative biomarkers which 
  13 
could help clinicians to differentiate depressed patients with subthreshold biploarity 
from the “true” UD patients. This exploratory study will encourage future in-depth 
investigations, such as functional connectivity analysis and task-based fMRI studies, 
to provide complementary information about the features of spontaneous brain activity 
in HCL-32(+) patients. 
Conflict of interest 
The authors declared no potential conflicts of interest with respect to the research, 
authorship, and/or publication of this article. 
References 
Angst, J., 1999. Major depression in 1998: are we providing optimal therapy? J Clin. 
Psychiatry 60 Suppl 6, 5-9. 
Angst, J., Adolfsson, R., Benazzi, F., Gamma, A., Hantouche, E., Meyer, T.D., Skeppar, P., Vieta, E., 
Scott, J., 2005. The HCL-32: towards a self-assessment tool for hypomanic symptoms in 
outpatients. J. Affect. Disord. 88, 217-233. 
Axmacher, N., Schmitz, D.P., Wagner, T., Elger, C.E., Fell, J., 2008. Interactions between medial 
temporal lobe, prefrontal cortex, and inferior temporal regions during visual working memory: a 
combined intracranial EEG and functional magnetic resonance imaging study. J. Neurosci. 28, 
7304-7312. 
Bechara, A., Damasio, A.R., Damasio, H., Anderson, S.W., 1994. Insensitivity to future consequences 
following damage to human prefrontal cortex. Cognition 50, 7-15. 
Biederman, J., Wozniak, J., Tarko, L., Serra, G., Hernandez, M., McDermott, K., Woodsworth, K.Y., 
Uchida, M., Faraone, S.V., 2014. Re-examining the risk for switch from unipolar to bipolar major 
depressive disorder in youth with ADHD: a long term prospective longitudinal controlled study. J. 
Affect. Disord. 152-154, 347-351. 
Biswal, B., Yetkin, F.Z., Haughton, V.M., Hyde, J.S., 1995. Functional connectivity in the motor cortex 
of resting human brain using echo-planar MRI. Magn. Reson. Med. 34, 537-541. 
Canli, T., Sivers, H., Thomason, M.E., Whitfield-Gabrieli, S., Gabrieli, J.D., Gotlib, I.H., 2004. Brain 
activation to emotional words in depressed vs healthy subjects. Neuroreport 15, 2585-2588. 
Chao-Gan, Y., Yu-Feng, Z., 2010. DPARSF: a MATLAB toolbox for “pipeline” data analysis of 
resting-state fMRI. Front. Syst. Neurosci. 4, 13. 
Chen, J.D., Liu, F., Xun, G.L., Chen, H.F., Hu, M.R., Guo, X.F., Xiao, C.Q., Wooderson, S.C., Guo, 
W.B., Zhao, J.P., 2012. Early and late onset, first-episode, treatment-naive depression: same 
clinical symptoms, different regional neural activities. J. Affect. Disord. 143, 56-63. 
de Almeida, J.R.C., Versace, A., Mechelli, A., Hassel, S., Quevedo, K., Kupfer, D.J., Phillips, M.L., 
2009. Abnormal amygdala-prefrontal effective connectivity to happy faces differentiates bipolar 
from major depression. Biol. Psychiatry 66, 451-459. 
Dutta, A., McKie, S., Deakin, J.F., 2014. Resting state networks in major depressive disorder. 
Psychiatry Res. 224, 139-151. 
Fang, J., Mao, N., Jiang, X., Li, X., Wang, B., Wang, Q., 2015. Functional and Anatomical Brain 
Abnormalities and Effects of Antidepressant in Major Depressive Disorder: Combined Application 
of Voxel-Based Morphometry and Amplitude of Frequency Fluctuation in Resting State. J. 
Comput. Assist. Tomogr. 39, 766-773. 
First, M.B., Gibbon, M., 1997. User's guide for the Structured clinical interview for DSM-IV axis I 
disorders SCID-I: clinician version. Amer Psychiatric Pub Incorporated. 
First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B.W., 2002a. Structured Clinical Interview for 
DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition. (SCID-I/NP). New York: 
  14 
Biometrics Research, New York State Psychiatric Institute. 
First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B.W., 2002b. Structured Clinical Interview for 
DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P). New York: 
Biometrics Research, New York State Psychiatric Institute. 
Fitzgerald, P.B., Laird, A.R., Maller, J., Daskalakis, Z.J., 2008. A meta-analytic study of changes in 
brain activation in depression. Hum. Brain Mapp. 29, 683-695. 
Fornaro, M., Ventriglio, A., De Pasquale, C., Pistorio, M.L., De Berardis, D., Cattaneo, C.I., Favaretto, 
E., Martinotti, G., Tomasetti, C., Elassy, M., D'Angelo, E., Mungo, S., Del Debbio, A., Romano, 
A., Ciampa, G., Colicchio, S., 2013. Sensation seeking in major depressive patients: relationship 
to sub-threshold bipolarity and cyclothymic temperament. J. Affect. Disord. 148, 375-383. 
Fox, M.D., Corbetta, M., Snyder, A.Z., Vincent, J.L., Raichle, M.E., 2006. Spontaneous neuronal 
activity distinguishes human dorsal and ventral attention systems. Proc. Natl. Acad. Sci. U. S. A. 
103, 10046-10051. 
Fox, M.D., Raichle, M.E., 2007. Spontaneous fluctuations in brain activity observed with functional 
magnetic resonance imaging. Nat. Rev. Neurosci. 8, 700-711. 
Geday, J., Kupers, R., Gjedde, A., 2007. As time goes by: temporal constraints on emotional activation 
of inferior medial prefrontal cortex. Cereb. Cortex 17, 2753-2759. 
Guo, W.B., Liu, F., Xue, Z.M., Yu, Y., Ma, C.Q., Tan, C.L., Sun, X.L., Chen, J.D., Liu, Z.N., Xiao, C.Q., 
Chen, H.F., Zhao, J.P., 2011. Abnormal neural activities in first-episode, treatment-naive, 
short-illness-duration, and treatment-response patients with major depressive disorder: a 
resting-state fMRI study. J. Affect. Disord. 135, 326-331. 
Hamilton, M., 1969. Standardised assessment and recording of depressive symptoms. Psychiatr. Neurol. 
Neurochir. 72, 201-205. 
Hirschfeld, R.M., Lewis, L., Vornik, L.A., 2003. Perceptions and impact of bipolar disorder: how far 
have we really come? Results of the national depressive and manic-depressive association 2000 
survey of individuals with bipolar disorder. J. Clin. Psychiatry 64, 161-174. 
Holma, K.M., Melartin, T.K., Holma, I.A., Isometsa, E.T., 2008. Predictors for switch from unipolar 
major depressive disorder to bipolar disorder type I or II: a 5-year prospective study. J. Clin. 
Psychiatry 69, 1267-1275. 
Hu, C., Xiang, Y.T., Ungvari, G.S., Dickerson, F.B., Kilbourne, A.M., Si, T.M., Fang, Y.R., Lu, Z., 
Yang, H.C., Chiu, H.F., Lai, K.Y., Hu, J., Chen, Z.Y., Huang, Y., Sun, J., Wang, X.P., Li, H.C., 
Zhang, J.B., Wang, G., 2012. Undiagnosed bipolar disorder in patients treated for major 
depression in China. J. Affect. Disord. 140, 181-186. 
Kemp, D.E., Hirschfeld, R.M., Ganocy, S.J., Elhaj, O., Slembarski, R., Bilali, S., Conroy, C., Pontau, J., 
Findling, R.L., Calabrese, J.R., 2008. Screening for bipolar disorder in a county jail at the time of 
criminal arrest. J. Psychiatr. Res. 42, 778-786. 
Kriegeskorte, N., Simmons, W.K., Bellgowan, P.S., Baker, C.I., 2009. Circular analysis in systems 
neuroscience: the dangers of double dipping. Nat. Neurosci. 12, 535-540. 
Kroes, M.C., Rugg, M.D., Whalley, M.G., Brewin, C.R., 2011. Structural brain abnormalities common 
to posttraumatic stress disorder and depression. J. Psychiatry Neurosci. 36, 256-265. 
Kunisato, Y., Okamoto, Y., Okada, G., Aoyama, S., Nishiyama, Y., Onoda, K., Yamawaki, S., 2011. 
Personality traits and the amplitude of spontaneous low-frequency oscillations during resting state. 
Neurosci. Lett. 492, 109-113. 
Liang, M.J., Zhou, Q., Yang, K.R., Yang, X.L., Fang, J., Chen, W.L., Huang, Z., 2013. Identify changes 
of brain regional homogeneity in bipolar disorder and unipolar depression using resting-state 
FMRI. PLoS One 8, e79999. 
Liu, C.H., Li, F., Li, S.F., Wang, Y.J., Tie, C.L., Wu, H.Y., Zhou, Z., Zhang, D., Dong, J., Yang, Z., 
2012a. Abnormal baseline brain activity in bipolar depression: A resting state functional magnetic 
resonance imaging study. Psychiatry Res. 203, 175-179. 
Liu, C.H., Ma, X., Li, F., Wang, Y.J., Tie, C.L., Li, S.F., Chen, T.L., Fan, T., Zhang, Y., Dong, J., 2012b. 
Regional Homogeneity within the Default Mode Network in Bipolar Depression: A Resting-State 
Functional Magnetic Resonance Imaging Study. PLoS One 7, e48181. 
  15 
Liu, C.H., Ma, X., Wu, X., Li, F., Zhang, Y., Zhou, F.C., Wang, Y.J., Tie, C.L., Zhou, Z., Zhang, D., 
2012c. Resting-state abnormal baseline brain activity in unipolar and bipolar depression. Neurosci. 
Lett. 516, 202-206. 
Liu, C.H., Ma, X., Wu, X., Zhang, Y., Zhou, F.C., Li, F., Tie, C.L., Dong, J., Wang, Y.J., Yang, Z., 
2012d. Regional homogeneity of resting-state brain abnormalities in bipolar and unipolar 
depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 41, 52-59. 
Liu, C.H., Ma, X., Wu, X., Zhang, Y., Zhou, F.C., Li, F., Tie, C.L., Dong, J., Wang, Y.J., Yang, Z., Wang, 
C.Y., 2013a. Regional homogeneity of resting-state brain abnormalities in bipolar and unipolar 
depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 41, 52-59. 
Liu, F., Guo, W., Liu, L., Long, Z., Ma, C., Xue, Z., Wang, Y., Li, J., Hu, M., Zhang, J., Du, H., Zeng, 
L., Liu, Z., Wooderson, S.C., Tan, C., Zhao, J., Chen, H., 2013b. Abnormal amplitude 
low-frequency oscillations in medication-naive, first-episode patients with major depressive 
disorder: a resting-state fMRI study. J. Affect. Disord. 146, 401-406. 
Liu, F., Hu, M., Wang, S., Guo, W., Zhao, J., Li, J., Xun, G., Long, Z., Zhang, J., Wang, Y., Zeng, L., 
Gao, Q., Wooderson, S.C., Chen, J., Chen, H., 2012e. Abnormal regional spontaneous neural 
activity in first-episode, treatment-naive patients with late-life depression: a resting-state fMRI 
study. Prog. Neuropsychopharmacol. Biol. Psychiatry 39, 326-331. 
Liu, Z., Xu, C., Xu, Y., Wang, Y., Zhao, B., Lv, Y., Cao, X., Zhang, K., Du, C., 2010. Decreased 
regional homogeneity in insula and cerebellum: a resting-state fMRI study in patients with major 
depression and subjects at high risk for major depression. Psychiatry Res. 182, 211-215. 
Lowe, M., Mock, B., Sorenson, J., 1998. Functional connectivity in single and multislice echoplanar 
imaging using resting-state fluctuations. Neuroimage 7, 119-132. 
Luo, Y., Huang, X., Yang, Z., Li, B., Liu, J., Wei, D., 2014. Regional Homogeneity of Intrinsic Brain 
Activity in Happy and Unhappy Individuals. PLoS One 9, e85181. 
Merikangas, K.R., Akiskal, H.S., Angst, J., Greenberg, P.E., Hirschfeld, R.M., Petukhova, M., Kessler, 
R.C., 2007. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National 
Comorbidity Survey replication. Arch. Gen. Psychiatry 64, 543-552. 
Murray, C.J., Lopez, A.D., 1997. Global mortality, disability, and the contribution of risk factors: 
Global Burden of Disease Study. Lancet 349, 1436-1442. 
Oldfield, R.C., 1971. The assessment and analysis of handedness: the Edinburgh inventory. 
Neuropsychologia 9, 97-113. 
Ongur, D., Price, J.L., 2000. The organization of networks within the orbital and medial prefrontal 
cortex of rats, monkeys and humans. Cereb. Cortex 10, 206-219. 
Phillips, M.L., Ladouceur, C.D., Drevets, W.C., 2008. A neural model of voluntary and automatic 
emotion regulation: implications for understanding the pathophysiology and neurodevelopment of 
bipolar disorder. Mol. Psychiatry 13, 829-857. 
Pomarol-Clotet, E., Moro, N., Sarro, S., Goikolea, J.M., Vieta, E., Amann, B., Fernandez-Corcuera, P., 
Sans-Sansa, B., Monte, G.C., Capdevila, A., McKenna, P.J., Salvador, R., 2012. Failure of 
de-activation in the medial frontal cortex in mania: evidence for default mode network 
dysfunction in the disorder. World J. Biol. Psychiatry 13, 616-626. 
Power, J.D., Barnes, K.A., Snyder, A.Z., Schlaggar, B.L., Petersen, S.E., 2012. Spurious but systematic 
correlations in functional connectivity MRI networks arise from subject motion. Neuroimage 59, 
2142-2154. 
Rolls, E.T., 1999. The Brain and Emotion. Oxford Univ. Press, Oxford, U.K. 
Schmahmann, J.D., 2004. Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar 
cognitive affective syndrome. J. Neuropsychiatry Clin. Neurosci. 16, 367-378. 
Schmahmann, J.D., Sherman, J.C., 1998. The cerebellar cognitive affective syndrome. Brain 121 ( Pt 
4), 561-579. 
Schraa-Tam, C.K., Rietdijk, W.J., Verbeke, W.J., Dietvorst, R.C., van den Berg, W.E., Bagozzi, R.P., De 
Zeeuw, C.I., 2012. fMRI activities in the emotional cerebellum: a preference for negative stimuli 
and goal-directed behavior. Cerebellum 11, 233-245. 
Sheline, Y.I., Price, J.L., Yan, Z., Mintun, M.A., 2010. Resting-state functional MRI in depression 
  16 
unmasks increased connectivity between networks via the dorsal nexus. Proc. Natl. Acad. Sci. U. 
S. A. 107, 11020-11025. 
Shippee, N.D., Shah, N.D., Williams, M.D., Moriarty, J.P., Frye, M.A., Ziegenfuss, J.Y., 2011. 
Differences in demographic composition and in work, social, and functional limitations among the 
populations with unipolar depression and bipolar disorder: results from a nationally representative 
sample. Health. Qual. Life Outcomes 9, 90. 
Solomon, D.A., Leon, A.C., Maser, J.D., Truman, C.J., Coryell, W., Endicott, J., Teres, J.J., Keller, 
M.B., 2006. Distinguishing bipolar major depression from unipolar major depression with the 
screening assessment of depression-polarity (SAD-P). J. Clin. Psychiatry 67, 434-442. 
Van Dijk, K.R., Sabuncu, M.R., Buckner, R.L., 2012. The influence of head motion on intrinsic 
functional connectivity MRI. Neuroimage 59, 431-438. 
Vargas, C., Lopez-Jaramillo, C., Vieta, E., 2013. A systematic literature review of resting state 
network--functional MRI in bipolar disorder. J. Affect. Disord. 150, 727-735. 
Versace, A., Thompson, W.K., Zhou, D., Almeida, J.R., Hassel, S., Klein, C.R., Kupfer, D.J., Phillips, 
M.L., 2010. Abnormal left and right amygdala-orbitofrontal cortical functional connectivity to 
emotional faces: state versus trait vulnerability markers of depression in bipolar disorder. Biol. 
Psychiatry 67, 422-431. 
Whitfield-Gabrieli, S., Ford, J.M., 2012. Default mode network activity and connectivity in 
psychopathology. Annu. Rev. Clin. Psychol. 8, 49-76. 
Wu, M., Andreescu, C., Butters, M.A., Tamburo, R., Reynolds, C.F., 3rd, Aizenstein, H., 2011. 
Default-mode network connectivity and white matter burden in late-life depression. Psychiatry 
Res. 194, 39-46. 
Wu, Q.Z., Li, D.M., Kuang, W.H., Zhang, T.J., Lui, S., Huang, X.Q., Chan, R.C.K., Kemp, G.J., Gong, 
Q.Y., 2010. Abnormal regional spontaneous neural activity in treatment‐refractory depression 
revealed by resting‐state fMRI. Hum. Brain Mapp. 32, 1290-1299. 
Yang, H.-C., Angst, J., Liao, C.-P., Yuan, C.-M., Wei, Z.-G., Wang, Y., Kong, Z., Yang, Y.-J., 2008. 
Preliminary study of the Chinese version of the 32-item hypomania checklist in patients with 
bipolar I disorder. Chin. J. Behavioral. Med. Sci. 17, 950-952. 
Yang, H.-C., Xiang, Y.-T., Liu, T.-B., Han, R., Wang, G., Hu, C., Li, L.-J., Wang, X.-P., Peng, H.-J., Si, 
T.-M., Fang, Y.-R., Yuan, C.-M., Lu, Z., Hu, J., Chen, Z.-Y., Huang, Y., Sun, J., Li, H.-C., Zhang, 
J.-B., Angst, J., 2012. Hypomanic symptoms assessed by the HCL-32 in patients with major 
depressive disorder: A multicenter trial across China. J. Affect. Disord. 143, 203-207. 
Yang, H.-C., Yuan, C.-M., Angst, J., Liu, T.-B., Liao, C.-P., Rong, H., 2010. Preliminary study of the 
Chinese version of the 32-item hypomania checklist in patients with bipolar II disorder. Chin. J. 
Clin. Psychiatry 20, 152-154. 
Yang, H., Yuan, C., Liu, T., Li, L., Peng, H., Liao, C., Rong, H., Fang, Y., Angst, J., 2011. Validity of 
the 32-item Hypomania Checklist (HCL-32) in a clinical sample with mood disorders in China. 
BMC Psychiatry 11, 84. 
Yao, Z., Wang, L., Lu, Q., Liu, H., Teng, G., 2009. Regional homogeneity in depression and its 
relationship with separate depressive symptom clusters: a resting-state fMRI study. J. Affect. 
Disord. 115, 430-438. 
Yu-Feng, Z., Yong, H., Chao-Zhe, Z., Qing-Jiu, C., Man-Qiu, S., Meng, L., Li-Xia, T., Tian-Zi, J., 
Yu-Feng, W., 2007. Altered baseline brain activity in children with ADHD revealed by 
resting-state functional MRI. Brain Dev. 29, 83-91. 
Zang, Y., Jiang, T., Lu, Y., He, Y., Tian, L., 2004. Regional homogeneity approach to fMRI data 
analysis. Neuroimage 22, 394-400. 
Zhang, J., Wang, J., Wu, Q., Kuang, W., Huang, X., He, Y., Gong, Q., 2011. Disrupted brain 
connectivity networks in drug-naive, first-episode major depressive disorder. Biol. Psychiatry 70, 
334-342. 
Zhou, Y., Yu, C., Zheng, H., Liu, Y., Song, M., Qin, W., Li, K., Jiang, T., 2010. Increased neural 
resources recruitment in the intrinsic organization in major depression. J. Affect. Disord. 121, 
220-230. 
  17 
Zuo, X.-N., Xing, X.-X., 2014. Test-retest reliabilities of resting-state FMRI measurements in human 
brain functional connectomics: A systems neuroscience perspective. Neurosci. Biobehav. Rev. 45, 
100-118. 
 
Fig. 1. ReHo differences between HCL-32(+) and HCL-32(-) (two-sample t-tests, 
thresholded at p < 0.05, AlphaSim corrected). Upper panel presents brain areas 
exhibiting significant higher ReHo value in HCL-32(+) than HCL-32(-) (axial view), 
including the left inferior parietal cortex (A), right medial superior frontal cortex (B) and 
left middle/inferior temporal cortex (C). Lower panel presents brain areas exhibiting 
significant lower ReHo value in HCL-32(+) than HCL-32(-) (coronal view), including 
the left postcentral cortex (D) and left cerebellum (E). The magnitudes and directions 
of the t score are presented by warm color (HCL-32(+) > HCL-32(-)) or cool color 
(HCL-32(+) < HCL-32(-)). 
Fig. 2. Receiver operating characteristic (ROC) curves for HCL-32(+) and HCL-32(-). 
ROI 1: the right medial superior frontal cortex; ROI 2: the left inferior parietal cortex; 
ROI 3: the left middle/inferior temporal cortex; ROI 4: the left postcentral cortex; ROI 5: 
the left cerebellum. 
 
Table 1. Demographic and clinical characteristics. 
 HCL-32(+) HCL-32(-) P-value
1
 MDD HC P-value
2
 
Gender (M/F) 9M/10F 9M/9F 0.873
a
 18M/19F 11M/13F 0.830
a
 
Age (years) 24.9 ± 5.7 27.1 ± 6.7 0.284
c
 26.0 ± 6.2 26.4 ± 3.9 0.756
c
 
Age range 18 - 35 18 - 45 — — 21 - 37 — 
EDU (years) 14.1 ± 2.4 12.8 ± 3.0 0.159
c
 13.5 ± 2.7 15.0 ± 3.3 0.055
c
 
DD (months) 19.0(36.0) 24.0(23.2) 0.807
b
 — — — 
Age of Onset (years) 22.0 ± 5.6 24.8 ± 5.7 0.141
 c
 23.4 ± 5.7 — — 
HAMA 28.5 ± 5.1 26.4 ± 5.3 0.230
c
 27.5 ± 5.2 8.5 ± 0.9 0.000
c
 
HDRS 31.8 ± 4.3 31.3 ± 5.0 0.715
c
 31.6 ± 4.6 6.9 ± 1.8 0.000
c
 
HCL-32 16.5 ± 2.9 6.3 ± 2.0 0.000
c
 — — — 
On    SSRIs 16 16 — — — — 
Venlafaxine 3 2 — — — — 
Data are expressed as mean ± SD or median(IQR); MDD: major depressive disorder; HCL-32: 32-item 
Hypomania checklist score; HCL-32(+): the MDD patients with HCL-32 score higher or equal to 12; 
HCL-32(-): the MDD patients with HCL-32 score lower than 12; HC: healthy control; EDU: years of 
education; DD: disease duration; HAMA: Hamilton Anxiety Rating Scale; HDRS: Hamilton Depression 
Rating Scale; SSRIs: selective serotonin reuptake inhibitors; P-value
1
: derived from statistical tests 
between HCL-32(+) and HCL-32(-); P-value
2
: derived from statistical tests between MDD and HC; 
a
: 
Indicates P values for Pearson Chi-square test; 
b
: Indicates P-values for Mann-Whitney U test; 
c
: 
Indicates P values for independent two-sample t-test. 
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Table 2. Brain regions exhibiting different regional homogeneity of MDD patients 
compared to HC. 
   MNI Coordinates   
Brain areas   X Y Z T N 
MDD > HC        
Superior Frontal Cortex (Medial) L BA 8, 9 -3 36 45 4.37 39 
 R BA 10 3 60 9 3.31 31 
Middle Frontal Cortex R BA 10, 46 27 54 24 4.38 89 
Inferior Frontal Cortex (Orbital) L BA 47 -39 24 -3 4.24 122 
 R BA 47 45 36 -12 3.90 14 
Inferior Frontal Cortex (Triangular) L BA 45 -48 45 12 3.05 32 
Inferior Parietal Cortex R BA 40 60 -30 30 4.77 64 
Angular Gyrus R BA 39 48 -63 36 3.54 44 
Precuneus L/R BA 23,7 6 -51 27 4.75 77 
ParaHippocampal Gryrus L BA 37 -27 -33 -9 3.73 32 
Insular R BA 47 39 15 3 3.60 26 
Cerebellum L  -18 -75 -30 4.54 142 
 R  15 -75 -30 4.61 82 
MDD < HC        
Postcentral cortex L BA 4 -45 -9 30 3.65 97 
 R BA 43 66 -6 27 5.04 271 
Superior Temporal Cortex L BA 22 -57 -15 6 4.80 210 
 R BA 22,48 60 -9 -3 3.81 107 
Inferior Occipital Cortex L BA 19 -51 -72 -9 3.81 22 
Middle Cingulate Cortex L/R BA 24 3 0 45 4.23 29 
x, y, z, coordinates of peak voxel in the MNI space; N: cluster size; MDD: major depressive disorder; HC: 
healthy control; BA: broadmann’s area. 
 
Table 3. Brain regions exhibiting different regional homogeneity of HCL-32(+) group 
compared to HCL-32(-) group. 
   MNI Coordinates   
Brain areas Side  X Y Z Peak T N 
HCL(+) > HCL(-)        
Superior Frontal Cortex (Medial)  R BA10 15 57 21 3.96 32 
Inferior Parietal Cortex L BA 40 -42 -36 39 3.82 19 
Middle/Inferior Temporal Cortex L BA 20,21 -66 -36 -12 4.90 26 
HCL(+) < HCL(-)        
Postcentral Cortex L BA 4 -15 -36 78 4.74 42 
Cerebellum L  -9 -51 -51 3.99 23 
x, y, z, coordinates of peak voxel in the MNI space; N:cluster size; BA, broadmann’s area; HCL-32(+): the 
MDD patients with HCL-32 score higher or equal to 12; HCL-32(-): the MDD patients with HCL-32 score 
lower than 12. 
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Table 4. ROC curves analyses between HCL-32(+) and HCL-32(-) 
Brain regions AUC Cut-off value Sensitivity Specificity 
MSFC (R) 0.845 1.05
a
 84% (16/19) 78% (14/18) 
IPC (L) 0.830 1.19 74% (14/19) 78% (14/18) 
MTC / ITC(L) 0.848 1.09 84% (16/19) 78% (14/18) 
Postcentral Cortex (L) 0.871 0.87 90% (17/19) 78% (14/18) 
Cerebellum (L) 0.871 0.71 84% (16/19) 83% (15/18) 
ROC: receiver operating characteristic; HCL-32(+): the MDD patients with HCL-32 score higher or equal 
to 12; HCL-32(-): the MDD patients with HCL-32 score lower than 12; AUC: area under the curve; 
a
: using 
this cut-off value, the mean ReHo value of right MSFC could correctly classify 16 of 19 HCL-32(+) 
patients and 14 of 18 HCL-32(-) patients, yielding a sensitivity of 84% and a specificity of 78%. The 
means of other cut-off values were similar. 
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HIGHLIGHTS 
 This is the first paper that the whole brain ReHo comparison analysis 
was examined between two MDD subgroups, which were divided based 
on HCL-32 scores by search the Pubmed of American National Library. 
It was also confirmed by the author (Jules Angst) of HCL-32. 
 The HCL-32 has been widely used as screening tool for BD in clinical 
psychiatry for the last 10 years. However, until now we did not know the 
different features in resting-state brain function of the patients positive 
for the HCL-32 (MDD HCL-32(+)) compared to the patients negative to 
HCL-32 (MDD HCL-32(-)). 
 We found that MDD HCL-32(+) showed significant increase of ReHo in 
right MSFC, left IPC, left MTC/ITC and significant decrease of ReHo in 
left postcentral cortex and left cerebellum compared to MDD HCL-32(-) 
patients. The changes in these brain areas differentiated HCL-32(+) 
patients from HCL-32(-) patients and may be putative biomarkers which 
differentiate bipolar depression from unipolar depressive disorder. 
 
 
